Sino Biological,Inc. (SHE:301047)
China
· Delayed Price · Currency is CNY 60.43
+0.03 (0.05%)
At close: Apr 30, 2025, 2:57 PM CST
Sino Biological,Inc. Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2017 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 | 2017 - 2019 |
| Net Income | 100.8 | 121.93 | 260.13 | 302.96 | 720.01 | 1,128 | Upgrade
|
| Depreciation & Amortization | 90.53 | 90.53 | 69.21 | 37.61 | 25.8 | 10.93 | Upgrade
|
| Other Amortization | 10.17 | 10.17 | 8.71 | 6.2 | 10.17 | 2 | Upgrade
|
| Loss (Gain) From Sale of Assets | 0.35 | 0.35 | -0.05 | -0.21 | 0.01 | - | Upgrade
|
| Asset Writedown & Restructuring Costs | - | - | - | - | 15.51 | 5.98 | Upgrade
|
| Loss (Gain) From Sale of Investments | -90.2 | -90.2 | -100.32 | -54.15 | -74.32 | -9.94 | Upgrade
|
| Provision & Write-off of Bad Debts | 8.26 | 8.26 | 11.05 | 0.26 | - | 10.43 | Upgrade
|
| Other Operating Activities | 26.11 | 6.26 | 15.8 | -16.2 | -9.13 | 0.12 | Upgrade
|
| Change in Accounts Receivable | -20.79 | -20.79 | 83.15 | 21.01 | 26.66 | -166.35 | Upgrade
|
| Change in Inventory | 14.39 | 14.39 | -21.94 | -32.98 | -17.73 | 6.23 | Upgrade
|
| Change in Accounts Payable | -9.72 | -9.72 | 16.66 | 8.06 | -74.04 | 138.69 | Upgrade
|
| Change in Other Net Operating Assets | 0.77 | 0.77 | 2.7 | 1.8 | 4.34 | -1.07 | Upgrade
|
| Operating Cash Flow | 112.45 | 113.73 | 322.56 | 249.39 | 642.62 | 1,093 | Upgrade
|
| Operating Cash Flow Growth | -63.31% | -64.74% | 29.34% | -61.19% | -41.20% | 2515.17% | Upgrade
|
| Capital Expenditures | -65.77 | -69.95 | -1,043 | -156.06 | -47.9 | -18.34 | Upgrade
|
| Sale of Property, Plant & Equipment | 0.24 | - | 0.03 | - | - | - | Upgrade
|
| Cash Acquisitions | -285.05 | -285.05 | - | - | - | - | Upgrade
|
| Investment in Securities | -180.2 | -167.18 | -220.75 | -19.51 | -2,541 | -1,025 | Upgrade
|
| Other Investing Activities | 82.51 | 86.28 | 76.1 | 111.42 | 40.31 | 3.54 | Upgrade
|
| Investing Cash Flow | -448.27 | -435.91 | -1,188 | -64.15 | -2,549 | -1,039 | Upgrade
|
| Long-Term Debt Repaid | - | -30.88 | -31.35 | -24.11 | -28.3 | -7.06 | Upgrade
|
| Total Debt Repaid | -30.88 | -30.88 | -31.35 | -24.11 | -28.3 | -7.06 | Upgrade
|
| Net Debt Issued (Repaid) | -30.88 | -30.88 | -31.35 | -24.11 | -28.3 | -7.06 | Upgrade
|
| Issuance of Common Stock | - | - | - | - | 4,741 | - | Upgrade
|
| Repurchase of Common Stock | -453.14 | -453.14 | - | - | - | - | Upgrade
|
| Common Dividends Paid | -255.52 | -255.52 | -258.4 | -680 | - | - | Upgrade
|
| Other Financing Activities | 101.32 | -0.1 | -0.22 | -0.16 | - | - | Upgrade
|
| Financing Cash Flow | -638.22 | -739.64 | -289.97 | -704.27 | 4,712 | -7.06 | Upgrade
|
| Foreign Exchange Rate Adjustments | -0.31 | -0.41 | -6.13 | 5.13 | 0.92 | -0.74 | Upgrade
|
| Net Cash Flow | -974.34 | -1,062 | -1,162 | -513.89 | 2,807 | 45.84 | Upgrade
|
| Free Cash Flow | 46.69 | 43.78 | -720.8 | 93.34 | 594.72 | 1,075 | Upgrade
|
| Free Cash Flow Growth | - | - | - | -84.31% | -44.66% | 13087.07% | Upgrade
|
| Free Cash Flow Margin | 7.57% | 7.13% | -111.51% | 16.24% | 61.61% | 67.32% | Upgrade
|
| Free Cash Flow Per Share | 0.37 | 0.34 | -5.58 | 0.82 | 5.52 | 11.09 | Upgrade
|
| Cash Income Tax Paid | 51.56 | 45.53 | -0.06 | 88.22 | 208.51 | 186.76 | Upgrade
|
| Levered Free Cash Flow | 98.62 | 72.87 | -871.24 | 28.46 | 364.82 | 798.92 | Upgrade
|
| Unlevered Free Cash Flow | 100.99 | 75.36 | -868.91 | 30.2 | 366.07 | 798.92 | Upgrade
|
| Change in Net Working Capital | -51.67 | -24.17 | -9.35 | -13.62 | 61.15 | 37.11 | Upgrade
|
Updated Oct 22, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.